ORPH PHARMA IP COMPANY LIMITED – Trademark Portfolio
Entity Type: 99
ORPH PHARMA IP COMPANY LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include POOLBEG PHARMA.
Queen Mary Bioenterprises
Innovation Centre, 42 New Road London E1
Showing of trademarks Trademarks
Trademark Classifications
ORPH PHARMA IP COMPANY LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ORPH PHARMA IP COMPANY LIMITED have?
ORPH PHARMA IP COMPANY LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ORPH PHARMA IP COMPANY LIMITED file in?
ORPH PHARMA IP COMPANY LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are ORPH PHARMA IP COMPANY LIMITED's most well-known trademarks?
ORPH PHARMA IP COMPANY LIMITED's registered trademark portfolio includes well-known marks such as POOLBEG PHARMA. These are among 1 currently registered trademark in the portfolio.
What is ORPH PHARMA IP COMPANY LIMITED's trademark registration success rate?
ORPH PHARMA IP COMPANY LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.